{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:12:42Z","timestamp":1788873162838,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014717","name":"National Outstanding Youth Science Fund Project of National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471715"],"award-info":[{"award-number":["82471715"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Ovarian cancer (OC) progression is one of the commonest cause of female cancer death. While treatments in clinic includes primary surgery and targeted chemotherapy, curative and survival trends in OC have not significantly improved. Thus, further investigation of the mechanisms regarding OC carcinogenesis and discovery of novel targets is of great importance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Human ovarian tissue specimens, RNA sequencing, GEPIA database and bioinformatics analyses were used to analyze the gene correlation, and to identify and validate potential downstream candidates. The biological effects of GPR137-RAB8A-Hedgehog(HH) were investigated using in vitro and in vivo models and methods including qRT-PCR, RNA stability assay, RNA immunoprecipitation assay, GLI-luciferase reporter assay, nucleo-cytoplasmic separation assay, membrane-cytoplasmic separation assay, western blot, co-immunoprecipitation, immunofluorescence staining, cell counting kit-8 assay, wound healing assay, matrigel invasion assay, colony formation assay, xenografts assay, in situ transplantation tumor model of ovarian cancer in nude mice, and immunohistochemistry staining.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      GPR137 expression was significantly higher in collected clinical OC tissues, compared with the adjacent normal tissues. Consistently, suppression of GPR137 inhibited human SK-OV-3 and A2780 OC cell proliferation, migration, invasion, and colony formation, whereas overexpression of GPR137 in human OC HO8910 cell exerted the opposite effects on cell biological behaviors. Mechanistically,\n                      <jats:italic>RAB8A<\/jats:italic>\n                      was identified as a downstream target of\n                      <jats:italic>GPR137<\/jats:italic>\n                      , and GPR137 promotes\n                      <jats:italic>RAB8A<\/jats:italic>\n                      expression by promoting\n                      <jats:italic>RAB8A<\/jats:italic>\n                      mRNA stability. By RNA-sequencing and experiments in vitro using multiple ovarian cancer cell models as well as in vivo using subcutaneous xenografts assay and in situ transplantation ovarian cancer model in nude mice, we further demonstrated that RAB8A positively mediated OC progression through activating HH signaling pathway by disassociating the protein\u2013protein complex formation of GLI and SuFu (Suppressor of Fused), which reciprocally enhanced GPR137 activity, forming a regulation loop between HH signaling and GPR137.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Collectively, this study depicts the role of GPR137-RAB8A-HH cascade in the development of OC, deepening our understanding of tumor biomechanics regarding OC progression and providing novel targets for OC therapy in future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13046-025-03275-0","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:59:26Z","timestamp":1737680366000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["GPR137-RAB8A activation promotes ovarian cancer development via the Hedgehog pathway"],"prefix":"10.1186","volume":"44","author":[{"given":"Chao","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,24]]},"reference":[{"issue":"1","key":"3275_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12943-021-01340-8","volume":"20","author":"F Xu","year":"2021","unstructured":"Xu F, Li J, Ni M, Cheng J, Zhao H, Wang S, Zhou X, Wu X. FBW7 suppresses ovarian cancer development by targeting the N(6)-methyladenosine binding protein YTHDF2. Mol Cancer. 2021;20(1):45.","journal-title":"Mol Cancer"},{"issue":"2","key":"3275_CR2","doi-asserted-by":"publisher","first-page":"188361","DOI":"10.1016\/j.bbcan.2020.188361","volume":"1873","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Wang C, Zhou S. Targeting tumor microenvironment in ovarian cancer: premise and promise. Biochim Biophys Acta Rev Cancer. 2020;1873(2):188361.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"3275_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.placenta.2023.11.006","volume":"144","author":"J Jiang","year":"2023","unstructured":"Jiang J, Li D, Zhong Y, Zhang Y, Zhong M. TET2-mediated DNA hydroxymethylation of TGFB1 is related to selective intrauterine growth restriction in monochorionic twin pregnancies. Placenta. 2023;144:45\u201354.","journal-title":"Placenta"},{"issue":"1","key":"3275_CR4","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1097\/AOG.0000000000004173","volume":"137","author":"KC Kurnit","year":"2021","unstructured":"Kurnit KC, Fleming GF, Lengyel E. Updates and new options in advanced epithelial ovarian cancer treatment. Obstet Gynecol. 2021;137(1):108\u201321.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"3275_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1186\/s12967-023-04462-3","volume":"21","author":"Q Xu","year":"2023","unstructured":"Xu Q, Yao M, Tang C. RGS2 and female common diseases: a guard of women\u2019s health. J Transl Med. 2023;21(1):583.","journal-title":"J Transl Med"},{"issue":"1","key":"3275_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13046-021-02091-6","volume":"40","author":"X Wei","year":"2021","unstructured":"Wei X, Lou H, Zhou D, Jia Y, Li H, Huang Q, Ma J, Yang Z, Sun C, Meng Y, Xu S, Yang X, Li X, Ji T, Guo Z, Gao Q. TAGLN mediated stiffness-regulated ovarian cancer progression via RhoA\/ROCK pathway. J Exp Clin Cancer Res. 2021;40(1):292.","journal-title":"J Exp Clin Cancer Res"},{"key":"3275_CR7","doi-asserted-by":"publisher","first-page":"745187","DOI":"10.3389\/fonc.2021.745187","volume":"11","author":"S Xu","year":"2021","unstructured":"Xu S, Tang C. The role of ARID1A in tumors: tumor initiation or tumor suppression? Front Oncol. 2021;11:745187.","journal-title":"Front Oncol"},{"issue":"1","key":"3275_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13062-023-00449-8","volume":"19","author":"L Li","year":"2024","unstructured":"Li L, Tang J, Cao B, Xu Q, Xu S, Lin C, Tang C. GPR137 inactivates Hippo signaling to promote gastric cancer cell malignancy. Biol Direct. 2024;19(1):3.","journal-title":"Biol Direct"},{"issue":"7","key":"3275_CR9","doi-asserted-by":"publisher","first-page":"e13986","DOI":"10.1111\/eci.13986","volume":"53","author":"L Li","year":"2023","unstructured":"Li L, Zhu C, Xu Q, Xu S, Ye J, Xu D, Wang L, Gan S, Liu B, Tang C. ALKBH1 contributes to renal cell carcinoma progression by reducing N6-methyladenine of GPR137. Eur J Clin Invest. 2023;53(7):e13986.","journal-title":"Eur J Clin Invest"},{"issue":"3","key":"3275_CR10","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1007\/s11064-022-03833-4","volume":"48","author":"K Iwasa","year":"2023","unstructured":"Iwasa K, Yamagishi A, Yamamoto S, Haruta C, Maruyama K, Yoshikawa K. GPR137 inhibits cell proliferation and promotes neuronal differentiation in the Neuro2a cells. Neurochem Res. 2023;48(3):996\u20131008.","journal-title":"Neurochem Res"},{"issue":"5","key":"3275_CR11","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/cbdd.12704","volume":"87","author":"J Ren","year":"2016","unstructured":"Ren J, Pan X, Li L, Huang Y, Huang H, Gao Y, Xu H, Qu F, Chen L, Wang L, Hong Y, Cui X, Xu D. Knockdown of GPR137, G Protein-coupled receptor 137, inhibits the proliferation and migration of human prostate cancer cells. Chem Biol Drug Des. 2016;87(5):704\u201313.","journal-title":"Chem Biol Drug Des"},{"key":"3275_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12935-018-0507-1","volume":"18","author":"LJ Men","year":"2018","unstructured":"Men LJ, Liu JZ, Chen HY, Zhang L, Chen SF, Xiao TW, Wang JX, Li GY, Wu YP. Down regulation of G protein-coupled receptor 137 expression inhibits proliferation and promotes apoptosis in leukemia cells. Cancer Cell Int. 2018;18:13.","journal-title":"Cancer Cell Int"},{"issue":"18","key":"3275_CR13","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.7150\/jca.87692","volume":"14","author":"L Ling","year":"2023","unstructured":"Ling L, Wen Y, Chen H, Xiong Y, Liu X, Chen J, Liu T, Zhang B. miR-134-3p driven by anisomycin impairs ovarian cancer stem cell activity through inhibiting GPR137 expression. J Cancer. 2023;14(18):3404\u201315.","journal-title":"J Cancer"},{"issue":"5","key":"3275_CR14","doi-asserted-by":"publisher","first-page":"330","DOI":"10.5301\/tj.5000703","volume":"104","author":"LQ Zhang","year":"2018","unstructured":"Zhang LQ, Yang SQ, Qu XD, Chen XJ, Lu HS, Wang Y. GRP137 promotes cell proliferation and metastasis through regulation of the PI3K\/AKT pathway in human ovarian cancer. Tumori. 2018;104(5):330\u20137.","journal-title":"Tumori"},{"issue":"4","key":"3275_CR15","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.str.2020.01.005","volume":"28","author":"D Waschbusch","year":"2020","unstructured":"Waschbusch D, Purlyte E, Pal P, McGrath E, Alessi DR, Khan AR. Structural Basis for Rab8a Recruitment of RILPL2 via LRRK2 Phosphorylation of Switch 2. Structure. 2020;28(4):406\u201341 (e6).","journal-title":"Structure"},{"issue":"1","key":"3275_CR16","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s10565-024-09866-5","volume":"40","author":"S Xu","year":"2024","unstructured":"Xu S, Cao B, Xuan G, Xu S, An Z, Zhu C, Li L, Tang C. Function and regulation of Rab GTPases in cancers. Cell Biol Toxicol. 2024;40(1):28.","journal-title":"Cell Biol Toxicol"},{"issue":"3","key":"3275_CR17","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.7150\/thno.67702","volume":"12","author":"C Tang","year":"2022","unstructured":"Tang C, Wu X, Ren Q, Yao M, Xu S, Yan Z. Hedgehog signaling is controlled by Rac1 activity. Theranostics. 2022;12(3):1303\u201320.","journal-title":"Theranostics"},{"key":"3275_CR18","doi-asserted-by":"publisher","first-page":"774291","DOI":"10.3389\/fcell.2022.774291","volume":"10","author":"S Xu","year":"2022","unstructured":"Xu S, Tang C. Cholesterol and hedgehog signaling: mutual regulation and beyond. Front Cell Dev Biol. 2022;10:774291.","journal-title":"Front Cell Dev Biol"},{"issue":"8","key":"3275_CR19","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/s41375-024-02313-8","volume":"38","author":"Q Li","year":"2024","unstructured":"Li Q, Liu Y, Wu J, Zhu Z, Fan J, Zhai L, Wang Z, Du G, Zhang L, Hu J, Ma DK, Liu JO, Huang H, Tan M, Dang Y, Jiang W. P4HA2 hydroxylates SUFU to regulate the paracrine Hedgehog signaling and promote B-cell lymphoma progression. Leukemia. 2024;38(8):1751\u201363.","journal-title":"Leukemia"},{"key":"3275_CR20","doi-asserted-by":"publisher","unstructured":"Xu S, Zhu C, Xu Q, An Z, Xu S, Xuan G, Lin C, Tang C. ARID1A restrains EMT and stemness of ovarian cancer cells through the Hippo pathway. Int J Oncol. 2024;65(2):76. https:\/\/doi.org\/10.3892\/ijo.2024.5664.","DOI":"10.3892\/ijo.2024.5664"},{"issue":"6","key":"3275_CR21","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00404-021-06323-0","volume":"305","author":"W Huang","year":"2022","unstructured":"Huang W, Chen L, Sun P. ERRalpha expression in ovarian cancer and promotes ovarian cancer cells migration in vitro. Arch Gynecol Obstet. 2022;305(6):1525\u201334.","journal-title":"Arch Gynecol Obstet"},{"key":"3275_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12935-020-01259-y","volume":"20","author":"Y Liu","year":"2020","unstructured":"Liu Y, Xu Y, Ding L, Yu L, Zhang B, Wei D. LncRNA MEG3 suppressed the progression of ovarian cancer via sponging miR-30e-3p and regulating LAMA4 expression. Cancer Cell Int. 2020;20:181.","journal-title":"Cancer Cell Int"},{"issue":"4","key":"3275_CR23","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jgg.2021.07.014","volume":"49","author":"H Zhu","year":"2022","unstructured":"Zhu H, Ren Q, Yan Z, Xu S, Luo J, Wu X, Tang C. Human HAND1 inhibits the conversion of cholesterol to steroids in trophoblasts. J Genet Genomics. 2022;49(4):350\u201363.","journal-title":"J Genet Genomics"},{"issue":"4","key":"3275_CR24","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1002\/cac2.12413","volume":"43","author":"D Miao","year":"2023","unstructured":"Miao D, Wang Q, Shi J, Lv Q, Tan D, Zhao C, Xiong Z, Zhang X. N6-methyladenosine-modified DBT alleviates lipid accumulation and inhibits tumor progression in clear cell renal cell carcinoma through the ANXA2\/YAP axis-regulated Hippo pathway. Cancer Commun (Lond). 2023;43(4):480\u2013502.","journal-title":"Cancer Commun (Lond)"},{"issue":"1","key":"3275_CR25","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s12276-023-00927-z","volume":"55","author":"C Tang","year":"2023","unstructured":"Tang C, Jin M, Ma B, Cao B, Lin C, Xu S, Li J, Xu Q. RGS2 promotes estradiol biosynthesis by trophoblasts during human pregnancy. Exp Mol Med. 2023;55(1):240\u201352.","journal-title":"Exp Mol Med"},{"issue":"11","key":"3275_CR26","first-page":"5215","volume":"15","author":"L Li","year":"2023","unstructured":"Li L, Zhu C, Xu S, Xu Q, Xu D, Gan S, Cui X, Tang C. PUS1 is a novel biomarker for evaluating malignancy of human renal cell carcinoma. Aging (Albany NY). 2023;15(11):5215\u201327.","journal-title":"Aging (Albany NY)"},{"key":"3275_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.isci.2018.01.003","volume":"1","author":"C Tang","year":"2018","unstructured":"Tang C, Takahashi-Kanemitsu A, Kikuchi I, Ben C, Hatakeyama M. Transcriptional Co-activator Functions of YAP and TAZ Are Inversely Regulated by Tyrosine Phosphorylation Status of Parafibromin. iScience. 2018;1:1\u201315.","journal-title":"iScience"},{"issue":"1","key":"3275_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12903-024-03894-7","volume":"24","author":"W Bulanawichit","year":"2024","unstructured":"Bulanawichit W, Sinsareekul C, Kornsuthisopon C, Chansaenroj A, Trachoo V, Nowwarote N, Osathanon T. Toll-like receptor and C-type lectin receptor agonists attenuate osteogenic differentiation in human dental pulp stem cells. BMC Oral Health. 2024;24(1):148.","journal-title":"BMC Oral Health"},{"issue":"1","key":"3275_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/03936155221140421","volume":"38","author":"C Liu","year":"2023","unstructured":"Liu C, Shen Y, Tan Q. Diagnostic and prognostic values of MMP-9 expression in ovarian cancer: A study based on bioinformatics analysis and meta-analysis. Int J Biol Markers. 2023;38(1):15\u201324.","journal-title":"Int J Biol Markers"},{"issue":"13","key":"3275_CR30","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1158\/0008-5472.CAN-23-2613","volume":"84","author":"JA Waters","year":"2024","unstructured":"Waters JA, Robinson M, Lujano-Olazaba O, Lucht C, Gilbert SF, House CD. Omental Preadipocytes Stimulate Matrix Remodeling and IGF Signaling to Support Ovarian Cancer Metastasis. Cancer Res. 2024;84(13):2073\u201389.","journal-title":"Cancer Res"},{"key":"3275_CR31","doi-asserted-by":"publisher","unstructured":"Choi J, Sung JY, Lee S, Yoo J, Rongo C, Kim YN, Shim J. Rab8 and Rabin8-Mediated Tumor Formation by Hyperactivated EGFR Signaling via FGFR Signaling. Int J Mol Sci. 2020;21(20):7770. https:\/\/doi.org\/10.3390\/ijms21207770.","DOI":"10.3390\/ijms21207770"},{"issue":"4","key":"3275_CR32","doi-asserted-by":"publisher","first-page":"10335","DOI":"10.1080\/21655979.2022.2063665","volume":"13","author":"H Ji","year":"2022","unstructured":"Ji H, Hu N. Circular RNA 0001823 aggravates the growth and metastasis of the cervical cancer cells through modulating the microRNA-613\/RAB8A axis. Bioengineered. 2022;13(4):10335\u201349.","journal-title":"Bioengineered"},{"key":"3275_CR33","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/1477-7819-12-371","volume":"12","author":"Y Bie","year":"2014","unstructured":"Bie Y, Zhang Z. RAB8A a new biomarker for endometrial cancer? World J Surg Oncol. 2014;12:371.","journal-title":"World J Surg Oncol"},{"key":"3275_CR34","doi-asserted-by":"publisher","unstructured":"Staubert C, Schoneberg T. GPCR Signaling From Intracellular Membranes - A Novel Concept. Bioessays. 2017;39(12). https:\/\/doi.org\/10.1002\/bies.201700200.","DOI":"10.1002\/bies.201700200"},{"issue":"3","key":"3275_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/21541248.2017.1302550","volume":"10","author":"S Shibata","year":"2019","unstructured":"Shibata S, Teshima Y, Niimi K, Inagaki S. Involvement of ARHGEF10, GEF for RhoA, in Rab6\/Rab8-mediating membrane traffic. Small GTPases. 2019;10(3):169\u201377.","journal-title":"Small GTPases"},{"issue":"8","key":"3275_CR36","doi-asserted-by":"publisher","first-page":"9250","DOI":"10.18632\/oncotarget.7062","volume":"7","author":"M Benvenuto","year":"2016","unstructured":"Benvenuto M, Masuelli L, De Smaele E, Fantini M, Mattera R, Cucchi D, Bonanno E, Di Stefano E, Frajese GV, Orlandi A, Screpanti I, Gulino A, Modesti A, Bei R. In vitro and in vivo inhibition of breast cancer cell growth by targeting the Hedgehog\/GLI pathway with SMO (GDC-0449) or GLI (GANT-61) inhibitors. Oncotarget. 2016;7(8):9250\u201370.","journal-title":"Oncotarget"},{"issue":"1","key":"3275_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41392-024-01803-6","volume":"9","author":"M Zhang","year":"2024","unstructured":"Zhang M, Chen T, Lu X, Lan X, Chen Z, Lu S. G protein-coupled receptors (GPCRs): advances in structures, mechanisms, and drug discovery. Signal Transduct Target Ther. 2024;9(1):88.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"3275_CR38","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/bab.1326","volume":"62","author":"X Cui","year":"2015","unstructured":"Cui X, Liu Y, Wang B, Xian G, Liu X, Tian X, Qin C. Knockdown of GPR137 by RNAi inhibits pancreatic cancer cell growth and induces apoptosis. Biotechnol Appl Biochem. 2015;62(6):861\u20137.","journal-title":"Biotechnol Appl Biochem"},{"issue":"6","key":"3275_CR39","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/bab.1329","volume":"62","author":"Y Du","year":"2015","unstructured":"Du Y, Bi W, Zhang F, Wu W, Xia S, Liu H. G-protein-coupled receptor 137 accelerates proliferation of urinary bladder cancer cells in vitro. Biotechnol Appl Biochem. 2015;62(6):855\u201360.","journal-title":"Biotechnol Appl Biochem"},{"key":"3275_CR40","doi-asserted-by":"publisher","first-page":"215629","DOI":"10.1016\/j.canlet.2022.215629","volume":"535","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang Z, Gao X, Ma Q, Yu Z, Huang S. Rab8A promotes breast cancer progression by increasing surface expression of Tropomyosin-related kinase B. Cancer Lett. 2022;535:215629.","journal-title":"Cancer Lett"},{"issue":"4","key":"3275_CR41","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1128\/MCB.01067-09","volume":"30","author":"A Sakane","year":"2010","unstructured":"Sakane A, Honda K, Sasaki T. Rab13 regulates neurite outgrowth in PC12 cells through its effector protein, JRAB\/MICAL-L2. Mol Cell Biol. 2010;30(4):1077\u201387.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"3275_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2015.04.002","volume":"363","author":"LY Zhu","year":"2015","unstructured":"Zhu LY, Zhang WM, Yang XM, Cui L, Li J, Zhang YL, Wang YH, Ao JP, Ma MZ, Lu H, Ren Y, Xu SH, Yang GD, Song WW, Wang JH, Zhang XD, Zhang R, Zhang ZG. Silencing of MICAL-L2 suppresses malignancy of ovarian cancer by inducing mesenchymal-epithelial transition. Cancer Lett. 2015;363(1):71\u201382.","journal-title":"Cancer Lett"},{"key":"3275_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/978-0-387-98094-2_11","volume":"149","author":"KW Cheng","year":"2009","unstructured":"Cheng KW, Agarwal R, Mills GB. Ras-superfamily GTP-ases in ovarian cancer. Cancer Treat Res. 2009;149:229\u201340.","journal-title":"Cancer Treat Res"},{"key":"3275_CR44","doi-asserted-by":"publisher","first-page":"8143581","DOI":"10.1155\/2023\/8143581","volume":"2023","author":"S Cai","year":"2023","unstructured":"Cai S, Liu X, Gao W, Ye L, Zhong Q, Zhang X. Transcription activation of Rab8A by PEA3 augments progression of esophagus cancer by activating the Wnt\/beta-catenin signaling pathway. Dis Markers. 2023;2023:8143581.","journal-title":"Dis Markers"},{"issue":"820","key":"3275_CR45","doi-asserted-by":"publisher","first-page":"eabo0465","DOI":"10.1126\/scisignal.abo0465","volume":"17","author":"Y Wang","year":"2024","unstructured":"Wang Y, Yao H, Zhang Y, Mu N, Lu T, Du Z, Wu Y, Li X, Su M, Shao M, Sun X, Su L, Liu X. TMEM216 promotes primary ciliogenesis and Hedgehog signaling through the SUFU-GLI2\/GLI3 axis. Sci Signal. 2024;17(820):eabo0465.","journal-title":"Sci Signal"},{"key":"3275_CR46","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.semcancer.2021.04.003","volume":"85","author":"J Jiang","year":"2022","unstructured":"Jiang J. Hedgehog signaling mechanism and role in cancer. Semin Cancer Biol. 2022;85:107\u201322.","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"3275_CR47","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/s42255-023-00828-5","volume":"5","author":"G Pontarollo","year":"2023","unstructured":"Pontarollo G, Kollar B, Mann A, Khuu MP, Kiouptsi K, Bayer F, Brandao I, Zinina VV, Hahlbrock J, Malinarich F, Mimmler M, Bhushan S, Marini F, Ruf W, Belheouane M, Baines JF, Endres K, Reba SM, Raker VK, Deppermann C, Welsch C, Bosmann M, Soshnikova N, Chassaing B, Bergentall M, Sommer F, Backhed F, Reinhardt C. Commensal bacteria weaken the intestinal barrier by suppressing epithelial neuropilin-1 and Hedgehog signaling. Nat Metab. 2023;5(7):1174\u201387.","journal-title":"Nat Metab"},{"issue":"4","key":"3275_CR48","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41594-024-01223-8","volume":"31","author":"N Hoppe","year":"2024","unstructured":"Hoppe N, Harrison S, Hwang SH, Chen Z, Karelina M, Deshpande I, Suomivuori CM, Palicharla VR, Berry SP, Tschaikner P, Regele D, Covey DF, Stefan E, Marks DS, Reiter JF, Dror RO, Evers AS, Mukhopadhyay S, Manglik A. GPR161 structure uncovers the redundant role of sterol-regulated ciliary cAMP signaling in the Hedgehog pathway. Nat Struct Mol Biol. 2024;31(4):667\u201377.","journal-title":"Nat Struct Mol Biol"},{"issue":"9","key":"3275_CR49","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/s41580-023-00591-1","volume":"24","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Beachy PA. Cellular and molecular mechanisms of Hedgehog signalling. Nat Rev Mol Cell Biol. 2023;24(9):668\u201387.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"3275_CR50","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1002\/cam4.4018","volume":"10","author":"Y Pan","year":"2021","unstructured":"Pan Y, Zhou J, Zhang W, Yan L, Lu M, Dai Y, Zhou H, Zhang S, Yang J. The Sonic Hedgehog signaling pathway regulates autophagy and migration in ovarian cancer. Cancer Med. 2021;10(13):4510\u201321.","journal-title":"Cancer Med"},{"issue":"4","key":"3275_CR51","doi-asserted-by":"publisher","first-page":"130557","DOI":"10.1016\/j.bbagen.2023.130557","volume":"1868","author":"Q Zhu","year":"2024","unstructured":"Zhu Q, Yang X, Lv Y. HERC4 modulates ovarian cancer cell proliferation by regulating SMO-elicited hedgehog signaling. Biochim Biophys Acta Gen Subj. 2024;1868(4):130557.","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"4","key":"3275_CR52","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s13402-020-00504-w","volume":"43","author":"S Sneha","year":"2020","unstructured":"Sneha S, Nagare RP, Sidhanth C, Krishnapriya S, Garg M, Ramachandran B, Murhekar K, Sundersingh S, Ganesan TS. The hedgehog pathway regulates cancer stem cells in serous adenocarcinoma of the ovary. Cell Oncol (Dordr). 2020;43(4):601\u201316.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"3275_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/carcin\/bgn230","volume":"30","author":"X Liao","year":"2009","unstructured":"Liao X, Siu MK, Au CW, Wong ES, Chan HY, Ip PP, Ngan HY, Cheung AN. Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis. 2009;30(1):131\u201340.","journal-title":"Carcinogenesis"},{"issue":"1","key":"3275_CR54","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1349-7006.2006.00353.x","volume":"98","author":"X Chen","year":"2007","unstructured":"Chen X, Horiuchi A, Kikuchi N, Osada R, Yoshida J, Shiozawa T, Konishi I. Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: it\u2019s inhibition leads to growth suppression and apoptosis. Cancer Sci. 2007;98(1):68\u201376.","journal-title":"Cancer Sci"},{"issue":"7","key":"3275_CR55","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1091\/mbc.e13-08-0493","volume":"25","author":"Y Sun","year":"2014","unstructured":"Sun Y, Chiu TT, Foley KP, Bilan PJ, Klip A. Myosin Va mediates Rab8A-regulated GLUT4 vesicle exocytosis in insulin-stimulated muscle cells. Mol Biol Cell. 2014;25(7):1159\u201370.","journal-title":"Mol Biol Cell"},{"key":"3275_CR56","doi-asserted-by":"publisher","first-page":"174679","DOI":"10.1016\/j.ejphar.2021.174679","volume":"916","author":"L Yin","year":"2022","unstructured":"Yin L, Zhang L, Luo L, Liu Y, Wang F, Feng Y, Wang H, Han Y, Yan Y, Huang C, Fan S. Berbamine reduces body weight via suppression of small GTPase Rab8a activity and activation of paraventricular hypothalamic neurons in obese mice. Eur J Pharmacol. 2022;916:174679.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"3275_CR57","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12929-016-0287-7","volume":"23","author":"HT Tzeng","year":"2016","unstructured":"Tzeng HT, Wang YC. Rab-mediated vesicle trafficking in cancer. J Biomed Sci. 2016;23(1):70.","journal-title":"J Biomed Sci"},{"issue":"7","key":"3275_CR58","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/s41419-018-0785-5","volume":"9","author":"X Zhang","year":"2018","unstructured":"Zhang X, Peng Y, Huang Y, Deng S, Feng X, Hou G, Lin H, Wang J, Yan R, Zhao Y, Fan X, Meltzer SJ, Li S, Jin Z. Inhibition of the miR-192\/215-Rab11-FIP2 axis suppresses human gastric cancer progression. Cell Death Dis. 2018;9(7):778.","journal-title":"Cell Death Dis"},{"issue":"2","key":"3275_CR59","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bbrc.2016.01.031","volume":"470","author":"CL Xu","year":"2016","unstructured":"Xu CL, Wang JZ, Xia XP, Pan CW, Shao XX, Xia SL, Yang SX, Zheng B. Rab11-FIP2 promotes colorectal cancer migration and invasion by regulating PI3K\/AKT\/MMP7 signaling pathway. Biochem Biophys Res Commun. 2016;470(2):397\u2013404.","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03275-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03275-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03275-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T01:45:24Z","timestamp":1737683124000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03275-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,24]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3275"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03275-0","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,24]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of Ruijin Hospital, Shanghai Jiaotong University School of Medicine institutional review board approved all the protocols of the study. All participants provided written informed consent for the use of ovarian carcinoma tissues and adjacent non-tumor tissues.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The author declares that all work described here has not been published before and that its publication has been approved by all co-authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}